No description, website, or topics provided.

Metsera, Inc. (Nasdaq: MTSR) (“Metsera”), a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormone (NuSH) analog peptides to treat obesity, ...

Permits have been filed for the construction of a 4-story residential building at 1848 Guerlain St. in the Parkchester ...

Day SEC Yield of 4.55% as of Jan. 30. Payable Jan 04; for shareholders of record Feb 03; ex-div Feb 03. More on  NuShares Enhanced Yield U.S.Aggregate Bond ETF Seeking Alpha’s Quant Rating on ...